Ambalal Sarabhai Enterprises logo

Ambalal Sarabhai Enterprises PE ratio, market cap and valuation

NSE: AMBALALSABSE: 500009Pharmaceuticals & BiotechnologySmall Cap

Last close ₹34.65down ₹1.79 (4.91%)BSE ₹34.60

Share price at the NSE close on 23 Oct 2026. Previous close ₹36.44.

52-week range of BSE trades to 23 Oct 2026
₹23.12Low, 28 Jan 2026₹49.98High, 20 Aug 2026
Market cap
₹266 Cr2,324th largest listed
P/E
19.6
P/B
1.7
Dividend yield
Nonein the last 12 months
ROE
9.1%
ROCE
5.0%
Debt to equity
0.33
Volume, NSE
46,405

Ambalal Sarabhai Enterprises PE ratio and valuation against its own history

Each ratio on 23 Oct 2026 beside its median over each window. The ratios are on standalone accounts to Mar 2019 and consolidated from Mar 2020. The PE ratio is the market cap over the profit of the last twelve months.

  • Price to earnings19.59today

    1 year

    Median 13.36

    Today is at or above 79% of the 247 days

    3 years

    Median 20.73

    Today is at or above 43% of the 611 days

    5 years

    Median 13.98

    Today is at or above 61% of the 1,107 days

  • Price to book1.68today

    1 year

    Median 1.57

    Today is at or above 65% of the 247 days

    3 years

    Median 2.08

    Today is at or above 23% of the 726 days

    5 years

    Median 1.99

    Today is at or above 24% of the 1,222 days

    10 years, since Nov 2018

    Median 2.60

    Today is at or above 15% of the 1,948 days

  • Price to sales1.29today

    1 year

    Median 1.21

    Today is at or above 73% of the 247 days

    3 years

    Median 1.58

    Today is at or above 30% of the 726 days

    5 years

    Median 1.33

    Today is at or above 45% of the 1,222 days

    10 years, since Jun 2017

    Median 1.38

    Today is at or above 44% of the 2,304 days

  • EV to EBITDA20.09today

    1 year

    Median 24.37

    Today is at or above 5% of the 247 days

    3 years

    Median 37.41

    Today is at or above 2% of the 726 days

    5 years

    Median 32.22

    Today is at or above 23% of the 1,222 days

  • Dividend yield0.00%today

    1 year

    Median 0.00%

    Today is at or above 100% of the 247 days

    3 years

    Median 0.00%

    Today is at or above 100% of the 744 days

    5 years

    Median 0.00%

    Today is at or above 100% of the 1,240 days

    10 years

    Median 0.00%

    Today is at or above 100% of the 2,480 days

  • Earnings yield5.11%today

    1 year

    Median 4.80%

    Today is at or above 60% of the 247 days

    3 years

    Median 4.42%

    Today is at or above 77% of the 611 days

    5 years

    Median 5.10%

    Today is at or above 50% of the 1,107 days

    10 years, since Jun 2017

    Median 4.68%

    Today is at or above 58% of the 2,141 days

Each track ranks every trading day in the window from the day the ratio was lowest to the day it was highest; the dot is today. The share under it is how many of those days the ratio was at or below today's level, so a high share means today is higher than on most days in the window. A window is shown only when the ratio is held on most of its trading days; a day after a loss-making year has no P/E. Dividend yield is in per cent. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.

How each ratio is worked out, with today's figures

The twelve months: Filed 12 AugThe balance sheet: Filed 21 May

  • Price to earnings =Market cap÷Net profit, last twelve months₹14 Cr
  • Price to book =Market cap÷Net worth₹158 Cr
  • Price to sales =Market cap÷Revenue, last twelve months₹205 Cr
  • Enterprise value =Market cap+Borrowings₹52 Cr−Cash₹19 Cr
  • EV to EBITDA =Enterprise value÷Operating profit, last twelve months₹15 Cr
  • Market cap =Close×Shares in issue7,66,33,296at 30 Sep 2026

Consolidated accounts, the twelve months to Jun 2026, balance sheet at Mar 2026, ₹ crore.Ambalal Sarabhai Enterprises financials ›

Ambalal Sarabhai Enterprises valuation at each year end

On the last trading day of each March, the month the company's year ends.

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Market cap (₹ crore)9582110146135267157349269186
Price to earningsNo full yearLossLoss62.85.14.811.9120.818.916.9
Price to bookNo balance sheetNo balance sheet4.44.72.42.41.32.71.91.3
Price to salesNo full year73.34.71.00.91.40.92.11.40.9
EV to EBITDANo full yearOperating lossOperating profit not statedOperating loss25.714.624.693.734.818.9
Dividend yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Earnings yieldNo full year−18.1%−3.8%1.6%19.7%20.6%8.4%0.8%5.3%5.9%
A ratio that does not exist on the day says why in its cell. The ratios are on standalone accounts to Mar 2019 and consolidated from Mar 2020.

Ambalal Sarabhai Enterprises market cap, ten years

The last trading day of each month.

Market cap, ₹ crore

  • Market cap

Earnings per share, book value and enterprise value

From the close on 23 Oct 2026, with the last twelve months' results.

Enterprise value
₹298 Cr
P/E to growth
3.35
Earnings per share
₹1.77
Book value per share
₹20.66
Dividends, last 12 months
None
Public's market cap
₹182 Cr

Against Pharmaceuticals

216 listed companies in Pharmaceuticals, each priced on its last trading day; Ambalal Sarabhai Enterprises is 117th among them by market cap. Each median leaves out Ambalal Sarabhai Enterprises itself and takes the other companies that have the figure.

Industry median P/E
28.3Across 155 other companies
Industry median P/B
2.9Across 186 other companies
Industry median EV/EBITDA
18.7Across 141 other companies
Industry median dividend yield
0.53%Across 89 other companies